In particular, we have shown that N-cad is a necessary mediator of CD138+ patient-derived multiple myeloma (MM) cells adhesion to the endosteum, and that down-regulation of N-cad in OSB decreased MM-OSB adhesive interactions, restricting the ex vivo survival of these tumor cells [4]. This evidence concerns the gene CDH2 and plasma cell myeloma.